Elanix’s Partner Transwell Biotech Completes Phase I of Phase I/II Clinical Trial with Progenitor Cell Treatment for Skin Graft Wounds

27-12-2017

Elanix’s Partner Transwell Biotech Completes Phase I of Phase I/II Clinical Trial with Progenitor Cell Treatment for Skin Graft Wounds